At SPERA PHARMA, we have added the latest 3D ED/MicroED (Three-Dimensional Electron Diffraction/Microcrystal Electron Diffraction) to our conventional X-ray analysis lineup, paving the way for a new chapter in...
At SPERA PHARMA, we have added the latest 3D ED/MicroED (Three-Dimensional Electron Diffraction/Microcrystal Electron Diffraction) to our conventional X-ray analysis lineup, paving the way for a new chapter in...
2022.09.20
[pdf-embedder url="https://www.spera-pharma.co.jp/wp-content/uploads/2022/09/220916_news_Notice-of-Change-of-Board-Members.pdf" title="220916_news_Notice of Change of Board Members"]
Osaka (Japan), February 16, 2022 – Interprotein Corporation and SPERA PHARMA, Inc. today hereby announce that we have signed an agreement for comprehensive collaboration aiming at research & development, m...
A paper by Masatoshi Yamada and others of the Pharmaceutical Research Division has been published in the academic journal "Organic Process Research & Development" of the American Chemical Society. 【Det...
A paper by Masatoshi Yamada and others of the Pharmaceutical Research Division has been published in the academic journal "Organic Process Research & Development" of the American Chemical Society. 【Det...
A paper by Masatoshi Yamada and others of the Pharmaceutical Research Division has been published in the academic journal "Organic Process Research & Development" of the American Chemical Society. 【Det...
The following monthly magazine, in which our researcher participated in writing, has been published. Book: PHARM STAGE Monthly, December 2019 Publication date: December 27, 2019 Theme: [Special Feature] M...
The following books, in which our researchers participated in writing, have been published.。 Book: Procedures for Implementing Technology Transfer (Test Method, Manufacturing Process) and Ensurin...
MORE
page top